Termilone on Track for Commercialization, BioProspect Reports

BioProspect's Termilone is based on Eremophilone Oil extracted from the native Australian tree species <em>Eremophila mitchellii</em>.

May 24, 2010

BRISBANE, Australia - BioProspect announced recent developments regarding its natural Australian termite solution Termilone for use as a timber treatment and as a soil-applied barrier to prevent termite infestation of buildings and other structures.

Termilone is based on Eremophilone Oil extracted from the native Australian tree species Eremophila mitchellii (False Sandalwood). The product has low mammalian toxicity, making it safe for pest control workers and household pets, in addition to having minimal environmental impact, the company reports.

BioProspect Chief Operating Officer Peter May said the company was actively progressing the Termilone project with the aim of registering end-use products with the Australian Pesticides & Veterinary Medicines Authority (APVMA), and had been encouraged by recent progress.

Click here to read the progress report.

 

Related